Key benefits Why people compare it 1 40-60% greater healing outcomes versus either peptide alone 2 Simultaneous activation of early-phase (TB-500) and mid-phase (BPC-157) repair 3 Synergistic upregulation of both VEGF/EGF and actin-migration pathways 4 Dual anti-inflammatory action: NO system modulation plus cytokine reduction 5 Single-vial reconstitution eliminates dosing variability 6 Optimized 1:1 mass ratio matching published combination protocols 7 Thorough tendon, ligament, muscle, and joint repair support 8 No emergent toxicity beyond individual component profiles Deep research About BPC-157 / TB-500 Blend This blend combines two structurally and mechanistically distinct peptides: BPC-157 (a 15-amino acid pentadecapeptide, MW ~1419 Da, sequence GEPPPGKPADDAGLV) and TB-500 (a synthetic 43-amino acid replica of Thymosin Beta-4, MW ~4921 Da)
Temperature-sensitive medications are subject to state and federal requirements and may take longer to ship
I mmune Activation B12 stimulates white blood cell production and macrophage scavengers that clean house
Thymosin Beta-4 was originally identified in the thymus gland and is now known to be present in high concentrations in wound fluid and blood platelets
Bioavailability: nearly 100%, bypasses GI absorption entirely Deficiency: first-line for pernicious anemia and malabsorption Dosing: weekly to monthly maintenance Prescription: yes, through Heally At home: yes, after provider guidance Daily tablets or lozenges
How do I start BPC-157 therapy at Dr